ACET
Price
$0.67
Change
+$0.01 (+1.52%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
55.47M
41 days until earnings call
PCRX
Price
$23.70
Change
-$0.22 (-0.92%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
1.36B
39 days until earnings call
Interact to see
Advertisement

ACET vs PCRX

Header iconACET vs PCRX Comparison
Open Charts ACET vs PCRXBanner chart's image
Adicet Bio
Price$0.67
Change+$0.01 (+1.52%)
Volume$5.75K
Capitalization55.47M
Pacira BioSciences
Price$23.70
Change-$0.22 (-0.92%)
Volume$6.97K
Capitalization1.36B
ACET vs PCRX Comparison Chart in %
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. PCRX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Buy and PCRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (ACET: $0.67 vs. PCRX: $23.71)
Brand notoriety: ACET and PCRX are both not notable
ACET represents the Biotechnology, while PCRX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 118% vs. PCRX: 63%
Market capitalization -- ACET: $55.47M vs. PCRX: $1.36B
ACET [@Biotechnology] is valued at $55.47M. PCRX’s [@Pharmaceuticals: Other] market capitalization is $1.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whilePCRX’s FA Score has 0 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • PCRX’s FA Score: 0 green, 5 red.
According to our system of comparison, ACET is a better buy in the long-term than PCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 5 TA indicator(s) are bullish while PCRX’s TA Score has 4 bullish TA indicator(s).

  • ACET’s TA Score: 5 bullish, 4 bearish.
  • PCRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than PCRX.

Price Growth

ACET (@Biotechnology) experienced а +0.24% price change this week, while PCRX (@Pharmaceuticals: Other) price change was -1.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.19%. For the same industry, the average monthly price growth was +14.45%, and the average quarterly price growth was +91.39%.

Reported Earning Dates

ACET is expected to report earnings on Aug 06, 2025.

PCRX is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (+0.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCRX($1.36B) has a higher market cap than ACET($55.5M). PCRX YTD gains are higher at: 25.849 vs. ACET (-30.291). PCRX has higher annual earnings (EBITDA): 155M vs. ACET (-110.82M). PCRX has more cash in the bank: 279M vs. ACET (150M). ACET has less debt than PCRX: ACET (16.2M) vs PCRX (586M). PCRX has higher revenues than ACET: PCRX (675M) vs ACET (0).
ACETPCRXACET / PCRX
Capitalization55.5M1.36B4%
EBITDA-110.82M155M-71%
Gain YTD-30.29125.849-117%
P/E RatioN/A32.74-
Revenue0675M-
Total Cash150M279M54%
Total Debt16.2M586M3%
FUNDAMENTALS RATINGS
ACET vs PCRX: Fundamental Ratings
ACET
PCRX
OUTLOOK RATING
1..100
655
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
52
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9793
PRICE GROWTH RATING
1..100
8856
P/E GROWTH RATING
1..100
17100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (32) in the Medical Distributors industry is in the same range as PCRX (52) in the Pharmaceuticals Other industry. This means that ACET’s stock grew similarly to PCRX’s over the last 12 months.

ACET's Profit vs Risk Rating (100) in the Medical Distributors industry is in the same range as PCRX (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew similarly to PCRX’s over the last 12 months.

PCRX's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as ACET (97) in the Medical Distributors industry. This means that PCRX’s stock grew similarly to ACET’s over the last 12 months.

PCRX's Price Growth Rating (56) in the Pharmaceuticals Other industry is in the same range as ACET (88) in the Medical Distributors industry. This means that PCRX’s stock grew similarly to ACET’s over the last 12 months.

ACET's P/E Growth Rating (17) in the Medical Distributors industry is significantly better than the same rating for PCRX (100) in the Pharmaceuticals Other industry. This means that ACET’s stock grew significantly faster than PCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETPCRX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTEX6.550.08
+1.24%
VTEX
PLD104.39-0.39
-0.37%
PROLOGIS
MNSO17.79-0.07
-0.39%
MINISO Group Holding Limited
AIRS4.74-0.16
-3.27%
AirSculpt Technologies
TELO1.70-0.08
-4.49%
Telomir Pharmaceuticals

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+1.91%
OGI - ACET
41%
Loosely correlated
+2.94%
RGNX - ACET
40%
Loosely correlated
+2.46%
SYRE - ACET
39%
Loosely correlated
+3.96%
DVAX - ACET
39%
Loosely correlated
+0.81%
ARWR - ACET
39%
Loosely correlated
+2.62%
More

PCRX and

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
-0.84%
ELAN - PCRX
32%
Poorly correlated
+3.92%
TEVA - PCRX
28%
Poorly correlated
-2.59%
ACET - PCRX
27%
Poorly correlated
+1.91%
SNDL - PCRX
26%
Poorly correlated
+2.46%
NBIX - PCRX
25%
Poorly correlated
-1.15%
More